Covista Inc. (CVSA)
NYSE: CVSA · Real-Time Price · USD
122.44
+2.22 (1.85%)
Jul 28, 2026, 10:40 AM EDT - Market open
Covista Financials Overview
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Revenue Revenue Growth | 1,910 | 1,788 | 1,585 | 1,451 | 1,382 | 899.25 |
Revenue Growth | 9.69% | 12.85% | 9.22% | 4.99% | 53.67% | 3.79% |
Gross Profit Gross Profit Growth | 1,094 | 1,017 | 886.1 | 802.34 | 722.07 | 441.34 |
Operating Income Operating Income Growth | 364.86 | 341.54 | 217.05 | 168.17 | 76.75 | 110.4 |
Net Income Net Income Growth | 234.06 | 237.07 | 136.78 | 93.36 | 310.99 | 140.05 |
Earnings Per Share EPS Growth | 6.40 | 6.18 | 3.39 | 2.05 | 6.43 | 1.36 |
EPS Growth | 6.14% | 82.30% | 65.37% | -68.12% | 372.79% | -66.59% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Chamberlain Chamberlain Growth | 744.26 | 725.77 | 633.52 | 571.03 | 557.54 | 563.81 |
Walden Walden Growth | 776.29 | 693.43 | 595.33 | 533.73 | 485.39 | - |
Medical and Veterinary Medical and Veterinary Growth | 389.26 | 369.09 | 355.8 | 346.07 | 338.91 | 335.43 |
Revenue (Total) Revenue (Total) Growth | 1,910 | 1,788 | 1,585 | 1,451 | 1,382 | 899.25 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Investments Cash & Investments Growth | 146.98 | 199.6 | 219.31 | 272.19 | 346.97 | 476.38 |
Total Debt Total Debt Growth | 736.29 | 774 | 847.85 | 896.19 | 1,067 | 1,292 |
Net Cash (Debt) Net Cash Growth | -589.32 | -574.4 | -628.55 | -624 | -719.76 | -815.39 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -16.18 | -14.98 | -15.59 | -13.68 | -14.87 | -15.79 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 406.15 | 337.9 | 295.78 | 191.91 | 10.6 | 192.2 |
Capital Expenditures CapEx Growth | -69.87 | -50.33 | -48.89 | -26.01 | -31.05 | -39.88 |
Free Cash Flow Free Cash Flow Growth | 336.28 | 287.57 | 246.88 | 165.9 | -20.45 | 152.32 |
Free Cash Flow Growth | 15.73% | 16.48% | 48.81% | - | - | 123.71% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Gross Margin | 57.28% | 56.86% | 55.92% | 55.30% | 52.25% | 49.08% |
Operating Margin | 19.10% | 19.10% | 13.70% | 11.59% | 5.55% | 12.28% |
Pretax Margin | 17.03% | 16.69% | 10.35% | 7.72% | -3.73% | 8.43% |
Profit Margin | 13.07% | 13.01% | 8.69% | 7.01% | -2.60% | 7.06% |
FCF Margin | 17.61% | 16.08% | 15.58% | 11.43% | -1.48% | 16.94% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | 19.07 | 20.59 | 20.12 | 16.75 | 5.59 | 26.21 |
Forward PE | 14.44 | 17.52 | 12.45 | 8.09 | 8.61 | 11.26 |
P/FCF Ratio | 12.38 | 15.91 | 10.41 | 8.76 | - | 11.52 |
PS Ratio | 2.18 | 2.56 | 1.62 | 1.00 | 1.18 | 1.95 |